|17th November 2020||Jonathan Will Mc Guire||104,254||Grant/award etc.||$0.00|
|3rd August 2020||Jonathan Will Mc Guire||10,000||Open or private purchase||$0.35||$3,500.00|
|22nd May 2020||Jonathan Will Mc Guire||10,000||Open or private purchase||$0.46||$4,648.00|
|19th May 2020||Jonathan Will Mc Guire||3,357||Sale back to the issuer||$5.29||$17,758.53|
|30th March 2020||Jonathan Will Mc Guire||125,000||Grant/award etc.||$0.00|
|20th February 2020||John T Blake||809||Sale back to the issuer||$5.44||$4,400.96|
|20th February 2020||William Patrick Ryan||1,133||Sale back to the issuer||$5.84||$6,616.72|
|20th February 2020||Jonathan Will Mc Guire||1,793||Open or private sale||$5.44||$9,753.92|
|19th February 2020||John T Blake||2,563||Grant/award etc.||$0.00|
|19th February 2020||William Patrick Ryan||3,594||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.
Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, CA. Its product, the Argus II Retinal Prosthesis System, treats outer retinal degenerations.